Three University of Wisconsin Stem Cell Patents Rejected
eldavojohn writes "A non-profit alumni group from the University of Wisconsin (WARF) has suffered a preliminary ruling against three of their recent patents regarding stem cells. Given that these patents have been upheld in prior rulings, there is a lot of speculation that they will be upheld in a future court case. From the PhysOrg article: 'The patents, which cover virtually all stem cell research in the country, have brought in at least $3.2 million and could net much more money before they expire in 2015, the newspaper said. Companies wanting to study the cells must buy licenses costing $75,000 to $400,000. The newspaper said WARF recently started waiving the fees if the research is conducted at universities or by non-profit groups.' Should universities (or groups within universities) be allowed to hold patents and intellectual property while at the same time gaining donations and grants as an educational institution — or for that matter government funds?"
It's not clear to me that they ever had a case for charging Universities or Non-profit groups, so it's odd that they mention that they have "started waiving the fees"
IANAL, but doesn't the Patent Research Exemption specifically mean that research does *not* require a license. Even companies can work on research and clinical trials and they don't need a licence as long as they don't begin commercial manufacture of the product within the patent term?
Should universities (or groups within universities) be allowed to hold patents
Well, if anyone should, then better the universities than companies. Apart from that, I would _not_ ever allow _anyone_ to hold _any_ patent in _any_ way related to human health and cure. Yes, I know what that would mean to "health" and drug companies.
I am putting myself to the fullest possible use, which is all I can think that any conscious entity can ever hope to do.
If anything completely government funded research would be worse, because the researchers have no incentive to complete their work. What's going to happen when these researchers find a cure? Their funding is going to be cut and they'll be out of work. If anything, they have incentive to string the government along because, unlike a pharmco Congress would not dare cut their funding. No Congressman wants to have to explain to his constituents how he is hindering their only hope of a cure by reducing funding.
The other benefit to pharmcos is competition. As I alluded to, if there is only one entity researching a cure, its only going to take one approach at a time to finding it. Contrast this with having several companies doing research. Each company is going to develop its own road map and take varied avenues to the research, effectively speeding up research as a whole. It's like the idea behind distributed computing. Why have one processor repeat same task 10 times when you can have 10 processors do each task once?
The sun beams down on a brand new day, No more welfare tax to pay, Unsightly slums gone up in flashing light...